

Cover Story
By Matthew Bin Han Ong
In a city that in recent years has come to epitomize the growing racial divide in wealth and health outcomes, Georgetown University’s Lombardi Comprehensive Cancer Center, with help from the Ralph Lauren Corporate Foundation, is establishing a patient navigation, screening, and education center to serve historically marginalized neighborhoods.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- CBER Director Vinay Prasad dared to “say no to drugs”
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
















